Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Category Archives: Cardiovascular Pharmacology
Edited Transcript of CYTK earnings conference call or presentation 31-Oct-19 8:30pm GMT – Yahoo Finance
Posted: Published on November 6th, 2019
South San Francisco Nov 6, 2019 (Thomson StreetEvents) -- Edited Transcript of Cytokinetics Inc earnings conference call or presentation Thursday, October 31, 2019 at 8:30:00pm GMT * Ching W. Jaw * Robert I. Blum H.C. Continue reading
Posted in Cardiovascular Pharmacology
Comments Off on Edited Transcript of CYTK earnings conference call or presentation 31-Oct-19 8:30pm GMT – Yahoo Finance
The Montreal Heart Institute celebrates its 500th heart transplant – GlobeNewswire
Posted: Published on November 6th, 2019
First heart transplant in Canada was performed at the Montreal Heart Institute First heart transplant in Canada was performed at the Montreal Heart Institute Fondation de lInstitut de Cardiologie de Montral MONTREAL, Quebec, Oct. 31, 2019 (GLOBE NEWSWIRE) -- The Montreal Heart Institute is proud to announce that the milestone of 500 heart transplants has been successfully completed recently. Continue reading
Posted in Cardiovascular Pharmacology
Comments Off on The Montreal Heart Institute celebrates its 500th heart transplant – GlobeNewswire
Potential PF Therapy AD-214 to Move into Phase 1 Testing in Humans – Pulmonary Fibrosis News
Posted: Published on November 6th, 2019
Investigational therapy AD-214 raised no safety concerns in preliminary studies in non-human primates, and AdAlta, the therapys developer, is now planning to launch a Phase 1 clinical trial in humans, the company announced. AD-214 is amodification of AdAltas original lead candidate for the treatment of pulmonary fibrosis (PF), AD-114. AD-214 contains two i-bodies modified antibodies that specifically target the protein CXCR4 Continue reading
Posted in Cardiovascular Pharmacology
Comments Off on Potential PF Therapy AD-214 to Move into Phase 1 Testing in Humans – Pulmonary Fibrosis News
The 9 Biggest Technology Trends That Will Transform Medicine And Healthcare In 2020 – Forbes
Posted: Published on November 6th, 2019
Healthcare is an industry that is currently being transformed using the latest technology, so it can meet the challenges it is facing in the 21st century. Technology can help healthcare organizations meet growing demand and efficiently operate to deliver better patient care. Here are 9 technology trends that will transform medicine and healthcare in 2020 Continue reading
Posted in Cardiovascular Pharmacology
Comments Off on The 9 Biggest Technology Trends That Will Transform Medicine And Healthcare In 2020 – Forbes
Advanced Drug Delivery Systems Market Growth Analysis 2019 to Share Key Aspects of the Industry with the details of Influence Factors Forecast to 2024…
Posted: Published on October 28th, 2019
The Advanced Drug Delivery Systems Market research report 2019-2024 focuses on the major drivers, restraints, opportunities and threats for key players. It also provides granular analysis of market share, segmentation, revenue forecasts and regional analysis till 2024. Continue reading
Posted in Cardiovascular Pharmacology
Comments Off on Advanced Drug Delivery Systems Market Growth Analysis 2019 to Share Key Aspects of the Industry with the details of Influence Factors Forecast to 2024…
Best supplements for blood pressure: The natural remedy proven to lower your reading – Express
Posted: Published on October 7th, 2019
High blood pressure is often branded the silent killer because it tends to creep up announced and only reveal itself when it is serious. The condition can raise a persons risk of developing deadly cardiovascular complications. Continue reading
Posted in Cardiovascular Pharmacology
Comments Off on Best supplements for blood pressure: The natural remedy proven to lower your reading – Express
Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as Chief Scientific Officer – Business Wire
Posted: Published on October 7th, 2019
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verve Therapeutics, a next-generation cardiovascular company developing therapies that safely edit the adult human genome to permanently reduce a persons risk of coronary artery disease, today announced the appointment of physician and scientist Andrew Bellinger, M.D., Ph.D., as the companys chief scientific officer. Dr Continue reading
Posted in Cardiovascular Pharmacology
Comments Off on Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as Chief Scientific Officer – Business Wire
G-Protein Coupled Receptors (GPCRs) Market Size And Prediction By Leading Manufacturers According To Its Application And Types Till 2022 – Space…
Posted: Published on October 7th, 2019
GPCRs market comprises assays and kits that aid in drug discovery and development. GPCRs is a large family of cell surface receptors that respond to a diverse range of external stimulus and play a major role in modern pharmacology due to their significant function in cell communication. More than 30% of the drugs available in the global market target GPCRs and most of the drugs that are currently under clinical and preclinical studies target this highly studied receptor protein Continue reading
Posted in Cardiovascular Pharmacology
Comments Off on G-Protein Coupled Receptors (GPCRs) Market Size And Prediction By Leading Manufacturers According To Its Application And Types Till 2022 – Space…
Yale alumna Dr. Nancy Brown named dean of Yale School of Medicine – Yale News
Posted: Published on September 18th, 2019
Dr. Continue reading
Posted in Cardiovascular Pharmacology
Comments Off on Yale alumna Dr. Nancy Brown named dean of Yale School of Medicine – Yale News
Former Executive Director of Preclinical Safety at Novartis, Klaus Peter Hoffmann, MD, PhD, Joins NDA Partners as Expert – Yahoo Finance
Posted: Published on September 18th, 2019
NDA Partners Chairman Carl Peck, MD, announced today that Klaus Peter Hoffmann, MD, PhD, a well-respected preclinical drug development expert with a focus in the cardiovascular and metabolic disease therapeutic areas, has joined the firm as an Expert Consultant. Dr. Continue reading
Posted in Cardiovascular Pharmacology
Comments Off on Former Executive Director of Preclinical Safety at Novartis, Klaus Peter Hoffmann, MD, PhD, Joins NDA Partners as Expert – Yahoo Finance